Rising Prevalence of Cardiovascular and Chronic Diseases
One of the main reasons the blood flow measurement device market is growing is that the number of people around the world who have cardiovascular diseases (CVD), diabetes, and associated chronic illnesses is increasing very quickly. Cardiovascular diseases still account for the largest percentage of deaths in the world, which means there is a huge amount of demand for accurate and timely diagnosis and monitoring equipment. Blood flow measurement devices are used to diagnose vascular abnormalities, assess for peripheral artery disease, and monitor the complications of diabetes, such as microvascular and macrovascular damage. Furthermore, as a result of the increase in lifestyle-related risk factors, such as obesity, hypertension, and inactivity, the number of patients who need to be monitored continuously is also rising. Assessing blood flow early and accurately helps physicians develop treatment plans specific to each patient, avoid severe complications from insufficient blood flow, and provide better overall care. In addition, the growing number of elderly people worldwide are at an increased risk for circulatory disorders, which will increase the need for reliable blood flow diagnostics.
Furthermore, because of their more favorable patient experience and greater efficiency than traditional methods of measuring blood flow, non-invasive and real-time blood flow measurement techniques are being used by health care providers more and more; as a result, hospitals, specialty clinics, and diagnostic centers are investing in highly advanced equipment to improve their ability to provide quality care. Overall, the need for these technologies for a wide range of clinical reasons, and increased efforts to raise awareness and improve screening processes are continually increasing demand for blood flow measurement technologies, thereby serving as a primary driver of the growth of this market.
Expansion in Emerging Markets and Remote Monitoring Solutions
The rapid growth of health care systems, an increasing number of chronic disease cases in developing countries and increasing interest in remote and point-of-care monitoring tools, provide opportunities to market blood flow measurement tools. There is improved access to health care in developing countries such as APAC, LATAM and ME, which is attributed to government investments in the health care system, increased disposable incomes and increased health insurance penetration. The expansion of health care services in both rural and urban locations will lead to an increase in access to blood flow measurement tools. The trends of telemedicine and remote monitoring were accelerated by the COVID-19 pandemic. This necessitates the use of portable, simple-to-use devices for continuous vascular health assessment outside of the clinic. Clinicians using wearable and handheld blood flow measurement tools are able to access real-time information to help them manage the care of patients with chronic diseases without needing to see them in person, thereby reducing the number of hospital visits and expenses associated with health care services.
Adding AI technology and connectivity into these devices will improve the diagnostic capability of the health care provider and allow them to create personalized treatment plans for the patient. Manufacturers developing low-cost, easy-to-use and connected blood flow measurement devices for the emerging market are well situated to take advantage of this opportunity for growth in the next decade due to their willingness to work collaboratively, manufacture locally and work within FDA regulations.
